A peer-reviewed animal study examines a combined senolytic immunotherapy and regenerative cell platform's translational implications for aging interventions.
Key Takeaways
- Therapy combination produced over 70% lifespan extension in aging animal models
- Combination improved liver injury, tissue repair, regenerative signaling, and biomarkers
- Researchers from Buck Institute, University of Miami, Cedars-Sinai, UC San Diego, and GWU contributed